4-[(5-ethyl-1,2,4-oxadiazol-3-yl)methyl]-3-oxo-N-[4-(propan-2-yl)phenyl]-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide
Chemical Structure Depiction of
4-[(5-ethyl-1,2,4-oxadiazol-3-yl)methyl]-3-oxo-N-[4-(propan-2-yl)phenyl]-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide
4-[(5-ethyl-1,2,4-oxadiazol-3-yl)methyl]-3-oxo-N-[4-(propan-2-yl)phenyl]-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide
Compound characteristics
| Compound ID: | L309-0535 |
| Compound Name: | 4-[(5-ethyl-1,2,4-oxadiazol-3-yl)methyl]-3-oxo-N-[4-(propan-2-yl)phenyl]-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide |
| Molecular Weight: | 456.52 |
| Molecular Formula: | C22 H24 N4 O5 S |
| Smiles: | CCc1nc(CN2C(COc3ccc(cc23)S(Nc2ccc(cc2)C(C)C)(=O)=O)=O)no1 |
| Stereo: | ACHIRAL |
| logP: | 3.9624 |
| logD: | 3.9592 |
| logSw: | -4.0451 |
| Hydrogen bond acceptors count: | 10 |
| Hydrogen bond donors count: | 1 |
| Polar surface area: | 97.323 |
| InChI Key: | ZQJFJVJBTKBUCH-UHFFFAOYSA-N |